Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection

• Status: Completed
• Trial end date: 2019-08-31
• Target enrollment: 0
• Participant gender: All

Summary

Randomized open label clinical trial to compare the clinical and microbiological efficacy of fecal microbiota transplantation, fidaxomicin, and vancomycin for relapsing Clostridium difficile infection

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Aarhus
• Treatments: Fidaxomicin; Vancomycin

Criteria

Inclusion Criteria:

1. Relapse of Clostridium difficile infection with previous trial of vancomycin or fidaxomicin

Exclusion Criteria:

1. Pregnancy or breastfeeding

2. Does not speak or understand the Danish language

3. Current antibiotic treatment other than metronidazole, vancomycin, fidaxomicin

4. fulminant colitis which contraindicates medical treatment

5. physician's evaluation that the patient cannot tolerate project inclusion